Cargando…
Design and Development of Novel Urea, Sulfonyltriurea, and Sulfonamide Derivatives as Potential Inhibitors of Sphingosine Kinase 1
Sphingosine kinase 1 (SphK1) is one of the well-studied drug targets for cancer and inflammatory diseases. Recently discovered small-molecule inhibitors of SphK1 have been recommended in cancer therapeutics; however, selectivity and potency of first-generation inhibitors are great challenge. In sear...
Autores principales: | Roy, Sonam, Mahapatra, Amarjyoti Das, Mohammad, Taj, Gupta, Preeti, Alajmi, Mohamed F., Hussain, Afzal, Rehman, Md. Tabish, Datta, Bhaskar, Hassan, Md. Imtaiyaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346089/ https://www.ncbi.nlm.nih.gov/pubmed/32526899 http://dx.doi.org/10.3390/ph13060118 |
Ejemplares similares
-
Identification of Sphingosine Kinase-1 Inhibitors
from Bioactive Natural Products Targeting Cancer Therapy
por: Jairajpuri, Deeba Shamim, et al.
Publicado: (2020) -
Evaluation of binding and inhibition mechanism of dietary phytochemicals with sphingosine kinase 1: Towards targeted anticancer therapy
por: Gupta, Preeti, et al.
Publicado: (2019) -
Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy
por: Gupta, Preeti, et al.
Publicado: (2021) -
Discovery of Harmaline as a Potent Inhibitor of Sphingosine
Kinase-1: A Chemopreventive Role in Lung Cancer
por: Roy, Sonam, et al.
Publicado: (2020) -
Insights into the Conserved Regulatory Mechanisms of Human and Yeast Aging
por: Dahiya, Rashmi, et al.
Publicado: (2020)